Join the conversation on nanomaterials, IUCLID and substitution
Are you on LinkedIn? We have recently set up three LinkedIn groups on nanomaterials, IUCLID and substitution, where you can share information and engage in the conversations. If you have a stake in one of these topics, we welcome your expertise.
As of 6 February, ECHA has received 15 070 registration dossiers for 6 560 substances manufactured or imported from one to 100 tonnes per year. These registrations cover
4 270 substances that have not been registered before. SMEs have submitted 16 % of the registrations. Follow the overall progress on our interactive infographic.
You can now watch a recording of last week's REACH 2018 Stakeholders' Day and view the presentations on the event page. The IT tool training will also be available as a recording this week. If you followed the event live on the day, we would love to hear your feedback.
Have your say on a proposal to restrict substances in tattoo inks
ECHA has assessed the risks and impact of substances used in tattoo inks on our health and proposed the need for an EU-wide restriction on their use.
We are now looking for early comments on all aspects of the proposed restriction, in particular on its workability, impact on the availability of colours, and alternatives for restricted pigments.
Send us your comments by 16 February 2018. They will be taken into account in the next meetings of the Committees for Risk Assessment and Socio-Economic Analysis when the committees discuss the proposal. The final deadline for comments is 20 June.
Have your say on a proposal to restrict perfluorocarboxylic acids, their salts and related substances
Send us your early comments on the restriction proposal for perfluorocarboxylic acids, their salts and related substances by 16 February. These comments will be taken into account in the next meetings of the Committees for Risk Assessment and Socio-Economic Analysis when the committees discuss the proposal. The final deadline for comments is 20 June.
Substances in nanoform: revision of REACH information requirements needed
The lack of hazard information hampers the risk assessment and identification of the potential need for further risk management measures for nanomaterials on the EU market. ECHA’s strategy for substances with nanoforms highlights the need for increased cooperation with Member States.
Catalogue of nanomaterials used in cosmetic products in the EU
The European Commission publishes a catalogue of nanomaterials used in cosmetic products in the EU. Many of the nanomaterials listed in the catalogue are also registered under REACH. The European Union Observatory for Nanomaterials (EUON) has published a table linking the substances in the catalogue to their registration data in ECHA’s chemicals database. There you can find more information about their safe use and what regulatory activities are relevant to them.
ECHA to update some List numbers to refer to ELINCS numbers
We have noticed that for some pre-registered substances both an ELINCS number and a List number have been assigned. To ease sharing of data and make sure that registrants of the same substance form only one joint submission, ECHA will update the List numbers of all affected pre-registrations to refer to the ELINCS number of the notified substance. The corresponding List numbers will become obsolete.
Also the affected List numbers for C&L notifications will be made obsolete and referred to the ELINCS number. The legal status of the pre-registrations and C&L notifications will not change.
The update only applies to substances for which no registration exists. A letter to inform those concerned will be sent out soon.
Watch a webinar: How are substances shortlisted and screened
The webinar explains the screening process, its timelines, and the criteria for shortlisting. It also covers how you can influence manual screening by updating your dossiers and where to get more information on common screening.
Watch Dr Kimmo Louekari from ECHA giving a presentation on the 3R approaches to acute oral toxicity testing. He explains the regulatory context of the test in REACH and describes an approach that allows for the waiving of the acute oral toxicity test under certain conditions and with a proper justification.
Recording: Poison centres workshop - preparing for new obligations
The second joint Commission and ECHA workshop on the implementation of Annex VIII to CLP took place on 1 February. It covered harmonised information to be notified to Member State appointed bodies for poison centres. It helps to understand legal obligations, how to fulfil them and how to get prepared now! Visit the Commission’s website for the presentations and a full recording of the discussion.
Public consultation on derogation to the exclusion criteria for cholecalciferol
Substances that normally should not be approved as active substances may be used if they meet one or more of the following derogation criteria: exposure is negligible; the active substance is essential to prevent a serious danger to human or animal health or the environment; or, not approving the substance would have a disproportionate negative impact on society when compared to the risks.
Give your comments on whether the conditions for derogation are met for cholecalciferol by 7 April 2018.
On 6 February, the European Commission published an amendment to the list of chemicals subject to an export notification (Annex I) and chemicals that are banned for export (Annex V) under the PIC Regulation. The amendment applies from 1 April 2018. However, to ensure continuity of your operations start submitting your export notifications for the new chemicals now!
Welcome to the ECHA website. This site is not fully supported in Internet Explorer 7 (and earlier versions). Please upgrade your Internet Explorer to a newer version.
